By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


CSL Behring 

1020 First Avenue
P.O. Box 61501
King of Prussia  Pennsylvania  19406-0901  U.S.A.
Phone: 610-878-4000 Fax: 610-878-4009



Company News
The Lancet Publishes CSL Behring's Kcentra Phase III Data 3/17/2015 7:25:40 AM
CSL Behring To Provide $80,000 In Scholarship Funding For Low-Income Students In Philadelphia Area 3/9/2015 10:36:44 AM
CSL Behring Continues Treatment Access Leadership By Donating Bleeding Disorder Protein Therapies IUs To World Federation Of Hemophilia 2/27/2015 10:31:03 AM
U.S. FDA Accepts For Review CSL Behring's Biologics License Application For rIX-FP For Hemophilia B Patients 2/4/2015 11:11:40 AM
Snag a Job: Here's How CSL Behring Makes Hiring Decisions 2/3/2015 4:51:41 PM
FDA Approves New Dosing Option for CSL Behring's Hizentra® 2/2/2015 9:20:36 AM
CSL Behring Submits Biologics License Application For FDA Approval Of Recombinant Fusion Protein Linking Coagulation Factor IX With Recombinant Albumin (Rix-FP) For Hemophilia B Patients 12/16/2014 8:36:38 AM
Startup Enable Injections Hiring As It Inks Deal With CSL Behring 11/12/2014 6:25:46 AM
CSL Behring Release: Evidence Presented At The 16th Biennial Meeting Of The European Society For Immunodeficiencies (ESID) Supports Individualized Dosing With Hizentra® 10/31/2014 8:32:59 AM
CSL Behring Announces Winners Of Its 13th Annual Gettin' In The Game(SM) Junior National Championship Program 10/29/2014 8:44:34 AM